Magic Mushroom Facts
Quick Answer
Psilocybin binds 5-HT2A receptors; effects last 4–6 hours. Microdose: 0.1–0.2g; moderate: 1.5–2.5g. Low physical toxicity; Oregon and Colorado have legal programs (2023, 2025).
Verified, research-backed information about psilocybin mushrooms. All facts are sourced from peer-reviewed studies and official sources.
Quick Facts by Category
What is Psilocybin?
- Psilocybin is a naturally occurring psychedelic compound found in over 200 species of mushrooms.
- When ingested, psilocybin is converted to psilocin, which binds to serotonin receptors in the brain.
- The primary mechanism of action involves the 5-HT2A serotonin receptor.
- Psilocybin was first isolated and named by Swiss chemist Albert Hofmann in 1958.
- The compound is classified as a Schedule I substance in the United States, though some jurisdictions have decriminalized or legalized it.
Effects & Duration
- Effects typically begin 20-40 minutes after ingestion and last 4-6 hours.
- Peak effects occur 1-3 hours after consumption.
- Common effects include visual distortions, altered perception of time, and emotional changes.
- Higher doses may produce ego dissolution or mystical-type experiences.
- After-effects (afterglow) can persist for 24 hours or longer, often characterized by improved mood.
Dosage Information
- A microdose is typically 0.1-0.3 grams of dried mushrooms (sub-perceptual effects).
- A low dose is 0.5-1.0 grams (mild effects, suitable for beginners).
- A moderate dose is 1.5-2.5 grams (full psychedelic experience).
- A high dose is 3.0-5.0 grams (intense experience, for experienced users).
- Potency varies significantly between strains; Penis Envy varieties are approximately 1.5-2x stronger than average.
Safety Profile
- Psilocybin has a very low toxicity profile; fatal overdose from psilocybin alone is extremely rare.
- The LD50 (lethal dose for 50% of subjects) in rats is 280 mg/kg, far exceeding any recreational dose.
- Psilocybin is not considered physically addictive and does not produce physical dependence.
- Tolerance develops rapidly, typically requiring 1-2 weeks between doses for full effects.
- Primary risks are psychological, including anxiety, panic, and triggering latent mental health conditions.
Research Findings
- Johns Hopkins research found psilocybin produced substantial decreases in depression and anxiety in cancer patients (Griffiths et al., 2016).
- A 2021 JAMA Psychiatry study showed psilocybin therapy was 4x more effective than traditional antidepressants for major depression.
- Imperial College London research demonstrated psilocybin increases connectivity between brain regions not normally connected.
- NYU research found 80% of cancer patients showed clinically significant reductions in anxiety and depression after psilocybin therapy.
- Johns Hopkins tobacco study (2014) and JAMA Psychiatry alcohol trial (2022) suggest psilocybin may help treat addiction.
Legal Status (US, 2026)
- Oregon legalized psilocybin for supervised therapeutic use in 2020 (Measure 109), with services beginning in 2023.
- Colorado legalized psilocybin for supervised use in 2022 (Proposition 122).
- Several cities have decriminalized psilocybin including Denver, Oakland, Santa Cruz, Ann Arbor, and Washington D.C.
- Psilocybin remains a Schedule I controlled substance under federal law.
- The FDA has granted 'Breakthrough Therapy' designation to psilocybin for treatment-resistant depression.
Frequently Asked Questions
Citing This Information
When referencing facts from PsyBear, please use the following citation format:
"Magic Mushroom Facts." PsyBear, https://psybear.co/facts, accessed July 2026.Important Disclaimer
This information is provided for educational purposes only and is not medical advice. Psilocybin is a controlled substance in most jurisdictions. Always consult healthcare professionals and verify local laws before making any decisions.